AGP Picks
View all

Healthcare Today Montana
Provided by AGP

Healthcare Today Montana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Montana.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 4, 2026

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
an hour ago

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire
MADONNA: CLUB CONFESSIONS AMSTERDAM WITH MISTR
an hour ago

MADONNA: CLUB CONFESSIONS AMSTERDAM WITH MISTR

Indeterminate GlobeNewswire
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
2 hours ago

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
2 hours ago

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

Indeterminate GlobeNewswire
AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection
3 hours ago

AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection

Indeterminate GlobeNewswire
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
6 hours ago

Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

Indeterminate GlobeNewswire
Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques
6 hours ago

Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques

Indeterminate GlobeNewswire
Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
6 hours ago

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Indeterminate GlobeNewswire
Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech
8 hours ago

Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech

Indeterminate GlobeNewswire
InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China
8 hours ago

InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Today Montana

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.